NEJM evidence.

ISSN 2766-5526Massachussetts Medical SocietyUnited States
ScopusMEDLINEPubMedPMCSCImagoMatched via identifier

Journal overview

Journal identity
Titles
NEJM Evidence
NEJM evidence.
NEJM Evid (abbreviated)
Key identifiers
ISSN
Not available
eISSN
2766-5526
NLM ID
9918317485806676
Publisher / basic metadata
Publisher
Massachussetts Medical Society
[Waltham, MA] : NEJM Group, a division of the Massachusetts Medical Society,[2022]-
Country
Language
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2022–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexed
Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
3.979
Best Quartile
Q1
H-index
19
Subject categories
  • Drug Discovery — Q1
  • Medicine (miscellaneous) — Q1
  • Pharmacology — Q1
More metrics
Coverage
2022–2025
Country
United States
Region
Northern America
Publisher
Massachussetts Medical Society
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
81
Total documents (3 years)
149
Total references
1719
Total citations (3 years)
921
Citable documents (3 years)
91
Citations per document (2 years)
6.2
References per document
21.22
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2766-5526
SCImago Source ID
21101207465
SCImago Rank (across all SCImago source types)
439

Publication activity

Publication activity
SCImago
2025
81 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Clinical Decision-Making; Clinical Trials as Topic; Evidence-Based Medicine
Coverage / history
Scopus:2022-2026
MEDLINE:MEDLINE: v1n1, Jan. 2022-In: PubMed: v1n1, Jan. 2022-;
PubMed:MEDLINE: v1n1, Jan. 2022-In: PubMed: v1n1, Jan. 2022-;